Tag: assisted reproductive technology market growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Assisted Reproductive Technology Industry In 2025?

The assisted reproductive technology market has experienced robust expansion in recent years. It is projected to grow from $34.35 billion in 2024 to $37.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.9%. Historically, this market’s growth can be attributed to an increase in infertility rates, changing societal norms, growing awareness, legislative support, and an aging population.

The assisted reproductive technology market size is projected to experience robust expansion over the coming years. This market is anticipated to reach a value of $52.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. Several factors contribute to this growth during the forecast period, including the growing maternal age, an increased desire for same-sex parenting, the rise of medical tourism, improvements in healthcare infrastructure, and advancements in research and development. Key developments expected within this period encompass the application of artificial intelligence (AI), the practice of egg freezing, single-embryo transfer (SET), PGT-A and genetic screening, alongside new fertility preservation methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Which Major Market Drivers Are Shaping The Future Of The Assisted Reproductive Technology Market?

The increasing incidence of infertility is projected to stimulate the assisted reproductive technology market in the foreseeable future. Infertility is characterized as the inability to conceive following twelve months of regular, unprotected sexual activity. This condition impacts both genders and is commonly identified through the failure to achieve pregnancy. Treatment for infertility often involves the use of assisted reproductive technology (ART). These therapies encompass methods that involve both female ova and male spermatozoa. For example, data from April 2023 released by the World Health Organization (WHO), an international public health body headquartered in Switzerland, indicates that millions globally of reproductive age face challenges with infertility, impacting their families and communities. Globally, approximately 1 in 6 adults, or about 17.5% of the adult population worldwide, are estimated to experience infertility. Consequently, the growing prevalence of infertility cases propels the expansion of the assisted reproductive technology market.

What Are The Major Segment Types Covered In The Assisted Reproductive Technology Market?

The assisted reproductive technologymarket covered in this report is segmented –

1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing

2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking

3) By End-User: Hospitals; Fertility Clinics; Other End-Users

Subsegments:

1) By Ovulation Testing: Urine Ovulation Predictor Kits; Saliva Ovulation Test Kits

2) By Hysterosalpingography (HSG): X-ray HSG; Sonohysterography (SHG)

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing; Anti-Müllerian Hormone (AMH) Testing; Antral Follicle Count (AFC) via Ultrasound

4) By Genetic Testing: Preimplantation Genetic Testing (PGT); Carrier Screening Tests; Genetic Compatibility Testing

What Trends Are Redefining The Assisted Reproductive Technology Market Dynamics?

Technological advancements stand out as a key trend gaining significant traction in the assisted reproductive technology market. Major companies operating in the assisted reproductive technology sector are dedicating efforts to developing technological solutions to strengthen their market standing. For instance, in October 2022, Alife Health, a US-based medical equipment manufacturing company, launched its Alife Assist platform. This suite of products is engineered to transform the in-vitro fertilization (IVF) process by leveraging data-driven insights and artificial intelligence (AI) to support clinical decision-making during critical IVF phases and to optimize the operations of fertility clinics. This innovative platform, which comprises Stim Assist, Embryo Assist, and Insights, provides comprehensive assistance to reproductive endocrinologists, embryologists, and clinic administrators, thereby improving medication dosing, embryo grading, and real-time performance monitoring, ultimately enhancing the patient experience and success rates in IVF procedures.

Which Key Players Are Driving Competition In The Assisted Reproductive Technology Market?

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

What Regional Growth Trends Are Shaping The Assisted Reproductive Technology Market Outlook?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Assisted Reproductive Technology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2025, By The Business Research Company

Prenatal Testing And Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Fertility Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the assisted reproductive technology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Assisted Reproductive Technology Market Expected to Grow Between 2025 And 2029?

The market size of assisted reproductive technology has increased significantly over the past few years. It is projected to rise from $34.35 billion in 2024 to $37.21 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. This growth during the historic period is due to factors such as rising infertility rates, evolving societal norms, increased awareness, supportive legislation, and an aging population.

The market size of assisted reproductive technology is set to rise substantially in the coming years. By 2029, it is projected to reach $52.84 billion, with a compound annual growth rate (CAGR) of 9.2%. This growth in the forecast period is primarily due to factors such as a rise in maternal age, an increase in the demand for same-sex parenting, blossoming medical tourism, growing healthcare infrastructure, and ongoing research and development. Significant emerging trends such as the utilization of artificial intelligence (AI), egg freezing, single-embryo transfer (SET), PGT-A and genetic screening, and advanced fertility preservation techniques are expected to define the forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

What are the Fundamental Drivers and Innovations Shaping the Assisted Reproductive Technology Market?

The anticipated surge in infertility incidences is poised to boost the assisted reproductive technology market in the future. Infertility, which pertains to the inability to conceive after engaging in regular unprotected sexual intercourse for a year, impacts both genders. Diagnosis typically hinges on conception failure. Assisted reproductive technology (ART) is utilized to treat infertility, encompassing fertility treatments involving both female eggs and male sperm. For instance, the World Health Organization (WHO), an international public health body based in Switzerland, stated in April 2023 that globally, countless reproductive-age individuals will grapple with infertility, affecting their families and communities. It is approximated that 1 in 6 adults worldwide, or roughly 17.5% of the global adult population, endure infertility troubles. Consequently, the escalating number of infertility incidences propels the expansion of the assisted reproductive technology market.

How Is the Assisted Reproductive Technology Market Segmented?

The assisted reproductive technology market covered in this report is segmented –

1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking

3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Subsegments:

1) By Ovulation Testing: Urine Ovulation Predictor Kits, Saliva Ovulation Test Kits

2) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound

4) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Which Regions Are Driving the Next Phase of the Assisted Reproductive Technology Market Growth?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Assisted Reproductive Technology Market?

A key trend gaining traction in the assisted reproductive technology market is the progress in technology. A primary focus for prominent companies operating in this market is the development of technological solutions to firm up their market position. An example of this is Alife Health, an American medical equipment manufacturer, which introduced the Alife Assist platform in October 2022. This revolutionary range of solutions is designed to transform the process of in-vitro fertilization (IVF) through the power of data-driven insights and artificial intelligence. These insights and AI aid key clinical decision-making stages of IVF and streamline fertility clinic operations. The innovative platform, consisting of Stim Assist, Embryo Assist, and Insights, provides holistic support to reproductive endocrinologists, embryologists, and clinic administrators. This results in optimised medication dosing, improved embryo grading, real-time performance monitoring, and overall enhanced success rates and patient experience in IVF procedures.

View the full report here:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

How Is the Assisted Reproductive Technology Market Defined and What Are Its Core Parameters?

Assisted reproductive technology is based on the surgical removal of eggs from women’s ovaries and then fusing them with men’s sperm in the laboratory to create embryos. These embryos are then inserted back into the woman’s body. ART uses donor eggs, donor sperm, or previously stored frozen embryos. Assisted reproductive technology (ART) is used for the treatment of infertility in either eggs or embryos.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5489

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Assisted Reproductive Technology Market?

The increasing incidence of infertility is anticipated to fuel the growth of the assisted reproductive technology market in the approaching years. Not being able to conceive after a year of frequent unprotected sex constitutes infertility. Both genders can be impacted by infertility, which is generally identified by the inability to conceive. Assisted reproductive technology (ART) serves as a treatment for infertility. This incorporates fertility treatments involving both female ovum and male sperm. For example, the World Health Organization (WHO), a Switzerland-based global health entity, stated in April 2023 that millions of reproductively-active individuals globally will grapple with infertility, affecting their families and their communities. On a global scale, infertility is estimated to affect 1 in 6 adults or approximately 17.5% of the world adult population. Hence, the surge in infertility cases propels the expansion of the assisted reproductive technology market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

How Has the Assisted Reproductive Technology Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

Rapid growth has been observed in the market size of assisted reproductive technology in the past few years. The market is expected to rise from $34.35 billion in 2024 to $37.21 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. Factors such as rising infertility rates, evolving societal norms, growing awareness about the technology, legislative backing, and an aging population have contributed significantly to the growth noted during the historic period.

Significant expansion is predicted for the assisted reproductive technology market, as it is anticipated to reach $52.84 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this surge during the forecast period include rising maternal age, growing demand for same-sex parenting, flourishing medical tourism, improving healthcare infrastructure, and advancements in research and development. The forecast period is also expected to witness trends like the implementation of artificial intelligence (AI), egg preservation, single-embryo transfer (SET), PGT-A, and genetic screening, along with the introduction of innovative fertility preservation strategies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5489

What New Market Trends Are Reshaping theAssisted Reproductive Technology Market and Its Opportunities?

Technological advancements is a key trend gaining the popularity in the assisted reproductive technology market. Major companies operating in the assisted reproductive technology are focused on developing technological solutions to strengthen their position. For instance, in October 2022, Alife Health, a US-based medical equipment manufacturing company launched Alife Assist platform, a suite of products designed to revolutionize the in-vitro fertilization (IVF) process by harnessing data-driven insights and artificial intelligence (AI) to aid clinical decision-making during key IVF stages and streamline the operations of fertility clinics. This innovative platform, comprised of Stim Assist, Embryo Assist, and Insights, offers comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators, improving medication dosing, embryo grading, and real-time performance monitoring, ultimately enhancing the patient experience and success rates in IVF procedures.

Who Are the Leading Market Players Fueling Growth in the Assisted Reproductive Technology Market Trend?

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

How is the Global Assisted Reproductive Technology Market Segemented?

The assisted reproductive technology market covered in this report is segmented –

1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking

3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Subsegments:

1) By Ovulation Testing: Urine Ovulation Predictor Kits, Saliva Ovulation Test Kits

2) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound

4) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Which Geographics are Influencing the Growth of the Assisted Reproductive Technology Market?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Assisted Reproductive Technology Maret 2025, By The Business Research Company:

IVF Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ivf-services-global-market-report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the assisted reproductive technology market grown in recent years?

There has been significant growth observed in the assisted reproductive technology market in the past years. The market value which is estimated to be $34.35 billion in 2024 is predicted to increase to $37.21 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. The past growth trend can be associated with factors such as increased infertility rates, evolving societal norms, enhanced awareness, legislative backing, and an aging population.

How is the assisted reproductive technology market size expected to evolve during the forecast period?

In the coming years, the assisted reproductive technology market is projected to experience robust growth. The market size is predicted to reach $52.84 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. Factors such as increasing maternal age, growing preference for same-sex parenting, medical tourism, burgeoning healthcare infrastructure, and research and development are contributing to this growth during the forecast period. The emergence of trends like artificial intelligence (AI) application, egg freezing, single-embryo transfer (SET), PGT-A, and genetic screening, as well as innovative fertility preservation techniques, further outline the prediction period.

Get your assisted reproductive technology market report here!

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Which key drivers are propelling the assisted reproductive technology market’s growth?

The rising number of infertility cases is expected to foster the assisted reproductive technology market in the coming years. Infertility is defined as the failure to become pregnant after a year of frequent and unprotected intercourse. Infertility affects both men and women, and is typically diagnosed by the inability to conceive. Infertility is treated using assisted reproductive technology (ART). Fertility therapies that work with both a woman’s egg and a man’s sperm are included in this. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based international public health organization, millions of people in the world who are of reproductive age will struggle with infertility, which will also influence their families and communities. Worldwide, it is estimated that 1 in 6 adults or around 17.5% of the global adult population struggle with infertility. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market.

What are the market segments in the assisted reproductive technology industry?

The assisted reproductive technology market covered in this report is segmented – _x000D_

_x000D_

1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing_x000D_

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking_x000D_

3) By End-User: Hospitals, Fertility Clinics, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Ovulation Testing: Urine Ovulation Predictor Kits, Saliva Ovulation Test Kits _x000D_

2) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG) _x000D_

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound _x000D_

4) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Which leading companies are shaping the growth of the assisted reproductive technology market?

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

What key trends are currently impacting the assisted reproductive technology market’s development?

The rise of technological innovations is becoming a significant trend in the assisted reproductive technology market. Prime companies in this sector are emphasizing on the creation of tech-based solutions to solidify their market stance. For example, Alife Health, an American medical equipment production firm, introduced the Alife Assist platform in October 2022. This suite of products aims to transform the process of in-vitro fertilization (IVF) by applying data-driven findings and artificial intelligence (AI) to help with crucial clinical decisions during significant IVF phases, and to make fertility clinic procedures more efficient. The revolutionary platform, which includes Stim Assist, Embryo Assist, and Insights, provides extensive assistance to reproductive endocrinologists, embryologists, and clinic administrators. As a result, it enhances medication dosing, embryo grading, real-time performance tracking, ultimately improving patient outcomes and success rates in IVF procedures.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5489

Which geographic areas are influencing the growth of the assisted reproductive technology market?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

IVF Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ivf-services-global-market-report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Rate is the Assisted Reproductive Technology Market Anticipated to Experience from 2025-2034?

The market size of assisted reproductive technology has seen substantial growth lately. It is set to increase from $34.35 billion in 2024 to $37.21 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. The historic growth can be linked to rising infertility rates, shifts in societal norms, heightened awareness, supportive legislature, and an aging population.

There is predicted to be a robust expansion in the assisted reproductive technology market in the coming years, with the market projected to reach $52.84 billion by 2029, growing at a CAGR of 9.2%. This growth during the forecast period is likely due to factors such as an increase in maternal age, a growing demand for same-sex parenting, a rise in medical tourism, broader healthcare infrastructure, and ongoing research and development. Key trends that will characterize this forecast period will involve the use of artificial intelligence (AI), egg preservation, single-embryo transfer (SET), PGT-A and genetic screening, as well as innovative techniques to preserve fertility.

Claim Your Free Sample of the Global Assisted Reproductive Technology Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

What Are the Primary Growth Drivers for the assisted reproductive technology Market?

The increasing incidence of infertility is anticipated to fuel the growth of the assisted reproductive technology market in the approaching years. Not being able to conceive after a year of frequent unprotected sex constitutes infertility. Both genders can be impacted by infertility, which is generally identified by the inability to conceive. Assisted reproductive technology (ART) serves as a treatment for infertility. This incorporates fertility treatments involving both female ovum and male sperm. For example, the World Health Organization (WHO), a Switzerland-based global health entity, stated in April 2023 that millions of reproductively-active individuals globally will grapple with infertility, affecting their families and their communities. On a global scale, infertility is estimated to affect 1 in 6 adults or approximately 17.5% of the world adult population. Hence, the surge in infertility cases propels the expansion of the assisted reproductive technology market.

What Are the Defining Segments of the Assisted Reproductive Technology Market?

The assisted reproductive technology market covered in this report is segmented – _x000D_

_x000D_

1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing_x000D_

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking_x000D_

3) By End-User: Hospitals, Fertility Clinics, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Ovulation Testing: Urine Ovulation Predictor Kits, Saliva Ovulation Test Kits _x000D_

2) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG) _x000D_

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound _x000D_

4) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

What Trends Are Revolutionizing Standards in the Assisted Reproductive Technology Market?

The rise in technological improvements is becoming an increasingly pivotal trend within the assisted reproductive technology market. Major companies within this sector are concentrating their efforts on creating technological solutions to fortify their market presence. As an example, in October 2022, Alife Health, an American medical equipment manufacturer, introduced their Alife Assist platform. This platform, created to transform the in-vitro fertilization (IVF) process, utilizes data-driven insights and artificial intelligence (AI) to aid in crucial clinical decisions during different stages of the IVF procedure and to enhance the operations of fertility clinics. This groundbreaking platform, which includes Stim Assist, Embryo Assist, and Insights, provides extensive support to reproductive endocrinologists, embryologists, and clinic administrators. The result is improved medication dosing, embryo grading, and real-time performance tracking, which significantly boosts both patient experience and successful IVF outcomes.

Order Now for Fast Delivery of Your Assisted Reproductive Technology Market Report!

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

What Regions Are Propelling Growth in the Assisted Reproductive Technology Industry?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Assisted Reproductive Technology Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the assisted reproductive technology market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Assisted Reproductive Technology Market Include

1. Assisted Reproductive Technology Market Executive Summary

2. Assisted Reproductive Technology Market Segments

3. Assisted Reproductive Technology Market Size And Template Market Growth Rate

4. Key Assisted Reproductive Technology Market Trends

5. Major Assisted Reproductive Technology Market Drivers

……

25. Key Mergers And Acquisitions In The Assisted Reproductive Technology Market

26. Top Assisted Reproductive Technology Companies

27. Assisted Reproductive Technology Market Opportunities And Strategies

28. Assisted Reproductive Technology Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

IVF Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ivf-services-global-market-report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: